A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.
Saved in:
| Title: | A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer. |
|---|---|
| Authors: | Wakelee, Heather1 hwakelee@stanford.edu, Gettinger, Scott2, Engelman, Jeffrey3, Jänne, Pasi4, West, Howard5, Subramaniam, Deepa6, Leach, Joseph7, Wax, Michael8, Yaron, Yifah9, Miles, Dale9, Lara, Primo10, Wakelee, Heather A11 (AUTHOR), Jänne, Pasi A12 (AUTHOR), Subramaniam, Deepa S13 (AUTHOR), Miles, Dale R14 (AUTHOR), Lara, Primo N Jr15 (AUTHOR) |
| Source: | Cancer Chemotherapy & Pharmacology. May2017, Vol. 79 Issue 5, p923-932. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
